Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -59.42% is 18% below its 5-year average of -50.48%, around the middle of its 5-year range (-102.77%–14.30%).
As of the fiscal period ended Tuesday, June 30, 2026. 14.91% below its 12-month average of -51.71%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -59.42%.
RETURN ON INVESTED CAPITAL (ROIC)
-59.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-51.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-39.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-50.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-64.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-14.91%
CURRENT VS 3Y AVG
-49.02%
CURRENT VS 5Y AVG
-17.70%
CURRENT VS 10Y AVG
+7.26%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.10%
median of 759 covered companies
CURRENT VS SECTOR MEDIAN
-74.24%
vs the sector median at left
Kiora Pharmaceuticals, Inc.
Market Cap
$11.46M
Return on Invested Capital (ROIC)
-59.42%
TTM Avg
-51.71%
3Y Avg
-39.87%
5Y Avg
-50.48%
Market Cap
$11.45M
Return on Invested Capital (ROIC)
-32.27%
TTM Avg
-112.80%
3Y Avg
-113.13%
5Y Avg
-94.20%
Market Cap
$11.11M
Return on Invested Capital (ROIC)
-127.37%
TTM Avg
-96.60%
3Y Avg
-79.17%
5Y Avg
-74.39%
Market Cap
$11.61M
Return on Invested Capital (ROIC)
-100.51%
TTM Avg
-100.10%
3Y Avg
-111.41%
5Y Avg
-95.28%
Market Cap
$11.12M
Return on Invested Capital (ROIC)
-216.67%
TTM Avg
-46.84%
3Y Avg
-98.66%
5Y Avg
-549.86%
Market Cap
$10.94M
Return on Invested Capital (ROIC)
-479.39%
TTM Avg
-317.58%
3Y Avg
-249.47%
5Y Avg
-183.14%
Market Cap
$11.11M
Return on Invested Capital (ROIC)
-240.64%
TTM Avg
-174.03%
3Y Avg
-198.05%
5Y Avg
-242.53%
Market Cap
$12.12M
Return on Invested Capital (ROIC)
-19.53%
TTM Avg
-16.13%
3Y Avg
-40.26%
5Y Avg
-33.39%
Market Cap
$10.96M
Return on Invested Capital (ROIC)
-465.34%
TTM Avg
-276.05%
3Y Avg
-276.05%
5Y Avg
-276.05%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiora Pharmaceuticals, Inc. (KPRX) | $11.46M | -59.42% | -51.71% | -39.87% | -50.48% |
| Biofrontera Inc. (BFRI)vs › | $11.45M | -32.27% | -112.80% | -113.13% | -94.20% |
| Pluri Inc. (PLUR)vs › | $11.11M | -127.37% | -96.60% | -79.17% | -74.39% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.61M | -100.51% | -100.10% | -111.41% | -95.28% |
| BioVie Inc. (BIVI)vs › | $11.12M | -216.67% | -46.84% | -98.66% | -549.86% |
| Cerenome, Inc. (CNSY)vs › | $10.94M | -479.39% | -317.58% | -249.47% | -183.14% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.11M | -240.64% | -174.03% | -198.05% | -242.53% |
| IRIDEX Corporation (IRIX)vs › | $12.12M | -19.53% | -16.13% | -40.26% | -33.39% |
| Caring Brands, Inc. (CABR)vs › | $10.96M | -465.34% | -276.05% | -276.05% | -276.05% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | -204.32% | -100.17% | -85.05% | -71.75% |
ROIC
-59.4%
ROE
-65.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -59.42% |
| 2026-03-31 | -69.88% |
| 2025-12-31 | -61.73% |
| 2025-09-30 | -29.64% |
| 2025-06-30 | -37.88% |
| 2025-03-31 | -38.32% |
| 2024-12-31 | 9.40% |
| 2024-09-30 | 14.30% |
| 2024-06-30 | 6.87% |
| 2024-03-31 | 6.35% |
| 2023-12-31 | -102.77% |
| 2023-09-30 | -95.14% |
| 2023-06-30 | -60.47% |
| 2023-03-31 | -73.92% |
| 2022-12-31 | -80.04% |
| 2022-09-30 | -81.57% |
| 2022-06-30 | -88.65% |
| 2022-03-31 | -77.03% |
| 2021-12-31 | -54.83% |
| 2021-09-30 | -38.15% |
| 2021-06-30 | -47.56% |
| 2021-03-31 | -35.84% |
| 2020-12-31 | -50.76% |
| 2020-09-30 | -100.01% |
| 2020-06-30 | -96.15% |
| 2020-03-31 | -86.97% |
| 2019-12-31 | -81.73% |
| 2019-09-30 | -104.34% |
| 2019-06-30 | -67.41% |
| 2019-03-31 | -66.30% |
| 2018-12-31 | -104.11% |
| 2018-09-30 | -100.27% |
| 2018-06-30 | -90.27% |
| 2018-03-31 | -210.01% |
| 2017-09-30 | -411.69% |
| 2017-06-30 | -182.16% |
| 2017-03-31 | -862.65% |
| 2016-12-31 | -550.94% |
| 2016-09-30 | -276.56% |
| 2016-06-30 | -134.13% |
| 2016-03-31 | -120.24% |
| 2015-12-31 | -109.71% |
| 2015-09-30 | -50.65% |
| 2015-06-30 | -397.63% |
| 2015-03-31 | -126.14% |
| 2013-12-31 | -2089.22% |
